ANTI-INHIBITOR COAGULANT COMPLEX

ANTI-INHIBITOR COAGULANT COMPLEX was reported 1104 times

ANTI-INHIBITOR COAGULANT COMPLEX is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI FACTOR VII ANTIBODY POSITIVE 2 0.1333
1 COAGULATION FACTOR XI LEVEL DECREASED 2 0.1250
2 ANTI FACTOR VIII ANTIBODY INCREASED 15 0.1210
3 ACQUIRED FACTOR VIII DEFICIENCY 1 0.1111
4 INHIBITING ANTIBODIES 5 0.0714
5 COAGULATION FACTOR XII LEVEL DECREASED 1 0.0625
6 ANTI FACTOR VIII ANTIBODY POSITIVE 30 0.0531
7 URETHRAL ABSCESS 1 0.0476
8 ANTI FACTOR IX ANTIBODY POSITIVE 1 0.0435
9 HAEMOPHILIC PSEUDOTUMOUR 1 0.0400
10 FACTOR VIII INHIBITION 39 0.0371
11 FACTOR IX INHIBITION 4 0.0323
12 FACTOR VII DEFICIENCY 2 0.0299
13 PSEUDOHYPERKALAEMIA 1 0.0294
14 PECTUS CARINATUM 1 0.0278
15 HAEMOPHILIC ARTHROPATHY 6 0.0251
16 MUSCLE NEOPLASM 1 0.0222
17 COAGULATION FACTOR IX LEVEL DECREASED 1 0.0175
18 INHIBITING ANTIBODIES POSITIVE 1 0.0175
19 SUBMANDIBULAR ABSCESS 1 0.0167
20 ANAMNESTIC REACTION 1 0.0161
21 FIBRINOLYSIS 1 0.0147
22 URETERIC HAEMORRHAGE 1 0.0145
23 ORAL MUCOSA HAEMATOMA 1 0.0137
24 ALLERGIC TRANSFUSION REACTION 2 0.0132
25 FACTOR VIII DEFICIENCY 2 0.0112
26 GASTROINTESTINAL ISCHAEMIA 3 0.0108
27 SPONTANEOUS HAEMORRHAGE 11 0.0107
28 SCROTAL HAEMATOMA 1 0.0105
29 PERIPHERAL PULSE DECREASED 1 0.0103
30 BACILLUS TEST POSITIVE 1 0.0101
31 SUBCLAVIAN ARTERY OCCLUSION 1 0.0099
32 TRAUMATIC HAEMORRHAGE 18 0.0096
33 PRODUCT RECONSTITUTION ISSUE 3 0.0095
34 REPETITIVE STRAIN INJURY 1 0.0088
35 SPINAL HAEMATOMA 1 0.0083
36 NEUTRALISING ANTIBODIES 1 0.0079
37 FLAVIVIRUS INFECTION 1 0.0078
38 HAEMARTHROSIS 65 0.0072
39 STRANGURY 1 0.0066
40 BUTTOCK INJURY 2 0.0066
41 ENTEROBACTER PNEUMONIA 1 0.0064
42 FACTOR V DEFICIENCY 1 0.0063
43 MUSCLE HAEMORRHAGE 25 0.0062
44 ACQUIRED HAEMOPHILIA 6 0.0060
45 PROTHROMBIN LEVEL INCREASED 2 0.0059
46 TRACHEAL HAEMORRHAGE 2 0.0057
47 SOFT TISSUE HAEMORRHAGE 2 0.0053
48 HEPATITIS B ANTIBODY POSITIVE 1 0.0053
49 LARYNGEAL INFLAMMATION 1 0.0053
50 CHEMICAL PERITONITIS 1 0.0051
51 THORACIC HAEMORRHAGE 1 0.0050
52 CAROTID ARTERY THROMBOSIS 4 0.0047
53 SPINAL CORD HAEMATOMA 1 0.0047
54 CARDIAC PERFORATION 1 0.0043
55 POST PROCEDURAL PULMONARY EMBOLISM 1 0.0043
56 CENTRAL VENOUS CATHETER REMOVAL 2 0.0043
57 TOOTH SOCKET HAEMORRHAGE 1 0.0042
58 PRE-EXISTING DISEASE 2 0.0041
59 THERAPY RESPONDER 2 0.0041
60 CAVERNOUS SINUS THROMBOSIS 1 0.0039
61 URTICARIA PAPULAR 1 0.0039
62 RENAL HAEMATOMA 2 0.0039
63 INFUSION SITE THROMBOSIS 1 0.0037
64 HEPATITIS C ANTIBODY POSITIVE 1 0.0037
65 PUTAMEN HAEMORRHAGE 1 0.0035
66 BLOOD FIBRINOGEN DECREASED 4 0.0035
67 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
68 FIBRIN DEGRADATION PRODUCTS INCREASED 1 0.0034
69 CATHETER SITE HAEMATOMA 1 0.0034
70 PROTEIN URINE 3 0.0033
71 SUPERIOR VENA CAVA SYNDROME 2 0.0033
72 ERYTHROPOIESIS ABNORMAL 1 0.0033
73 COAGULATION FACTOR V LEVEL DECREASED 1 0.0031
74 CATHETER SITE BRUISE 1 0.0030
75 INFLAMMATION OF WOUND 1 0.0030
76 HAEMORRHAGE 285 0.0027
77 CENTRAL LINE INFECTION 1 0.0027
78 AORTIC THROMBOSIS 3 0.0026
79 SKIN ULCER HAEMORRHAGE 1 0.0026
80 TONGUE HAEMORRHAGE 3 0.0026
81 LUNG CYST 1 0.0025
82 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 2 0.0025
83 TINEA PEDIS 4 0.0025
84 OBSTRUCTIVE UROPATHY 1 0.0025
85 RED BLOOD CELL TRANSFUSION 1 0.0024
86 PHARYNGEAL HAEMORRHAGE 3 0.0024
87 ATRIAL THROMBOSIS 5 0.0024
88 HAEMOBILIA 1 0.0024
89 JOINT WARMTH 3 0.0024
90 TRAUMATIC INTRACRANIAL HAEMORRHAGE 2 0.0022
91 NECROSIS ISCHAEMIC 1 0.0022
92 GALLBLADDER RUPTURE 1 0.0022
93 GASTRITIS BACTERIAL 1 0.0021
94 PATIENT UNCOOPERATIVE 1 0.0021
95 THERAPY PARTIAL RESPONDER 32 0.0020
96 BODY HEIGHT INCREASED 1 0.0020
97 MOUTH INJURY 3 0.0020
98 OESOPHAGEAL ULCER HAEMORRHAGE 1 0.0020
99 KELOID SCAR 1 0.0019
100 OCCULT BLOOD 1 0.0019
101 PHARYNGEAL MASS 1 0.0019
102 TRAUMATIC HAEMATOMA 2 0.0019
103 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
104 HAEMORRHAGIC DISORDER 2 0.0018
105 THERAPEUTIC PRODUCT INEFFECTIVE 7 0.0018
106 LUNG INFECTION PSEUDOMONAL 1 0.0018
107 CATHETER SITE INFLAMMATION 1 0.0018
108 POSTOPERATIVE ILEUS 1 0.0018
109 GASTRIC POLYPS 4 0.0018
110 SUBCLAVIAN VEIN THROMBOSIS 2 0.0018
111 HAEMORRHAGE SUBCUTANEOUS 6 0.0017
112 HAEMATOMA MUSCLE 2 0.0017
113 POSTOPERATIVE THROMBOSIS 1 0.0017
114 PANNICULITIS 4 0.0017
115 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
116 CATHETER SITE HAEMORRHAGE 4 0.0016
117 TREATMENT FAILURE 132 0.0016
118 HYPOPROTEINAEMIA 3 0.0016
119 GASTROINTESTINAL EROSION 1 0.0016
120 DEVICE RELATED SEPSIS 3 0.0015
121 RENAL VEIN THROMBOSIS 1 0.0015
122 PATIENT-DEVICE INCOMPATIBILITY 1 0.0015
123 PELVIC FLUID COLLECTION 1 0.0014
124 GLASSY EYES 1 0.0014
125 PULMONARY SEPSIS 2 0.0014
126 MOUTH HAEMORRHAGE 10 0.0014
127 DISSEMINATED INTRAVASCULAR COAGULATION 19 0.0013
128 SERRATIA INFECTION 1 0.0013
129 CATHETER SITE RELATED REACTION 1 0.0013
130 HAEMOLYTIC URAEMIC SYNDROME 3 0.0013
131 INFECTION PARASITIC 1 0.0013
132 OESOPHAGEAL CANDIDIASIS 5 0.0013
133 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
134 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
135 VENA CAVA THROMBOSIS 2 0.0012
136 COVID-19 IMMUNISATION 1 0.0012
137 HAEMATOMA 31 0.0012
138 VEIN RUPTURE 2 0.0012
139 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
140 HEPATITIS A 1 0.0012
141 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 1 0.0012
142 VITAL FUNCTIONS ABNORMAL 1 0.0012
143 TONGUE PRURITUS 1 0.0012
144 TRANSFUSION REACTION 1 0.0011
145 INFUSION SITE DISCHARGE 2 0.0011
146 INFUSION SITE DISCOLOURATION 1 0.0011
147 NECROTISING FASCIITIS 4 0.0011
148 UPPER AIRWAY OBSTRUCTION 1 0.0011
149 FIBRIN D DIMER INCREASED 4 0.0011
150 BONE CYST 1 0.0011
151 PROTHROMBIN LEVEL DECREASED 1 0.0011
152 HAEMOTHORAX 3 0.0010
153 HAEMORRHAGIC STROKE 8 0.0010
154 CARDIAC ANEURYSM 1 0.0010
155 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
156 THROMBOPHLEBITIS SUPERFICIAL 3 0.0010
157 HYPERURICAEMIA 4 0.0010
158 AXILLARY MASS 1 0.0010
159 GINGIVAL BLEEDING 13 0.0010
160 URINARY BLADDER HAEMORRHAGE 2 0.0009
161 BONE DEMINERALISATION 1 0.0009
162 HEPATIC NEOPLASM MALIGNANT 2 0.0009
163 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
164 THROMBOTIC MICROANGIOPATHY 9 0.0009
165 LARYNGEAL CANCER 1 0.0009
166 DIVERTICULUM INTESTINAL HAEMORRHAGIC 2 0.0009
167 KLEBSIELLA SEPSIS 1 0.0009
168 SPLENECTOMY 1 0.0009
169 SHOCK HAEMORRHAGIC 7 0.0009
170 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
171 PRODUCT PACKAGING CONFUSION 2 0.0008
172 CEREBRAL ARTERY EMBOLISM 1 0.0008
173 FEBRILE CONVULSION 1 0.0008
174 WOUND HAEMORRHAGE 3 0.0008
175 RETROPERITONEAL HAEMORRHAGE 2 0.0008
176 INTERVERTEBRAL DISC OPERATION 1 0.0008
177 JOINT INJURY 17 0.0008
178 POSTOPERATIVE WOUND COMPLICATION 1 0.0008
179 SUBCUTANEOUS HAEMATOMA 1 0.0008
180 DEVICE RELATED INFECTION 12 0.0008
181 ASPERGILLOSIS 1 0.0008
182 CALCULUS BLADDER 1 0.0007
183 SUBDURAL HAEMORRHAGE 2 0.0007
184 ECHOCARDIOGRAM ABNORMAL 1 0.0007
185 PERIPHERAL ARTERY THROMBOSIS 1 0.0007
186 PERIPHERAL ARTERY OCCLUSION 1 0.0007
187 CEREBELLAR HAEMORRHAGE 1 0.0007
188 RENAL INFARCT 1 0.0007
189 POST PROCEDURAL HAEMORRHAGE 8 0.0007
190 HYPERTRIGLYCERIDAEMIA 4 0.0007
191 POOR VENOUS ACCESS 7 0.0007
192 STEROID DIABETES 1 0.0007
193 MARASMUS 1 0.0007
194 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
195 INTRACARDIAC THROMBUS 2 0.0007
196 PULMONARY HAEMORRHAGE 5 0.0006
197 INFUSION SITE SWELLING 4 0.0006
198 HYPOVOLAEMIC SHOCK 3 0.0006
199 SKULL FRACTURE 1 0.0006
200 TROPONIN I INCREASED 1 0.0006
201 ENTEROBACTER INFECTION 1 0.0006
202 POST PROCEDURAL HAEMATOMA 1 0.0006
203 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
204 EROSIVE OESOPHAGITIS 1 0.0006
205 BLADDER NEOPLASM 1 0.0006
206 ECCHYMOSIS 4 0.0006
207 RIGHT VENTRICULAR FAILURE 4 0.0006
208 NEUTROPENIC SEPSIS 4 0.0006
209 TETANY 1 0.0005
210 CATHETER SITE INFECTION 2 0.0005
211 OSTEOPOROTIC FRACTURE 1 0.0005
212 MOUTH SWELLING 3 0.0005
213 METABOLIC DISORDER 3 0.0005
214 ATROPHY 1 0.0005
215 ABDOMINAL WALL HAEMATOMA 1 0.0005
216 PYELONEPHRITIS ACUTE 1 0.0005
217 ISCHAEMIC STROKE 9 0.0005
218 CORONARY ARTERY THROMBOSIS 1 0.0005
219 EAR HAEMORRHAGE 1 0.0005
220 RENAL HAEMORRHAGE 1 0.0005
221 LARYNGEAL OEDEMA 3 0.0005
222 TONGUE BITING 1 0.0005
223 INFUSION SITE EXTRAVASATION 3 0.0005
224 LIMB INJURY 13 0.0005
225 RENAL NEOPLASM 1 0.0005
226 CATHETER SITE ERYTHEMA 1 0.0005
227 INFUSION SITE BRUISING 1 0.0005
228 PERICARDIAL HAEMORRHAGE 1 0.0005
229 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
230 RENAL COLIC 1 0.0004
231 HAEMATURIA 15 0.0004
232 ARTHRITIS INFECTIVE 2 0.0004
233 SKIN ABRASION 2 0.0004
234 VARICELLA 1 0.0004
235 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
236 GLOMERULONEPHRITIS 1 0.0004
237 STAPHYLOCOCCAL SEPSIS 2 0.0004
238 HAEMORRHAGE INTRACRANIAL 6 0.0004
239 VEIN DISORDER 2 0.0004
240 VENTRICULAR HYPERTROPHY 1 0.0004
241 ERYSIPELAS 2 0.0004
242 DRUG TOLERANCE 2 0.0004
243 ENDODONTIC PROCEDURE 1 0.0004
244 DIABETIC COMPLICATION 1 0.0004
245 LACTOSE INTOLERANCE 1 0.0004
246 ENDOCARDITIS 2 0.0004
247 HEPATOSPLENOMEGALY 1 0.0004
248 CATHETER SITE PAIN 1 0.0004
249 COMPARTMENT SYNDROME 1 0.0004
250 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
251 FOLLICULITIS 4 0.0004
252 LARYNGOSPASM 1 0.0004
253 WEIGHT BEARING DIFFICULTY 1 0.0004
254 CHONDROPATHY 1 0.0004
255 INTESTINAL ISCHAEMIA 2 0.0004
256 EMBOLISM 3 0.0004
257 THERAPEUTIC RESPONSE DELAYED 1 0.0004
258 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
259 CEREBRAL THROMBOSIS 1 0.0004
260 GENERALISED ERYTHEMA 2 0.0004
261 TUMOUR HAEMORRHAGE 1 0.0004
262 DUODENAL ULCER HAEMORRHAGE 1 0.0003
263 GASTROINTESTINAL NECROSIS 1 0.0003
264 HEPATITIS C 4 0.0003
265 EMERGENCY CARE 1 0.0003
266 BLOOD BLISTER 1 0.0003
267 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
268 HIATUS HERNIA 4 0.0003
269 CEREBRAL HAEMORRHAGE 11 0.0003
270 OEDEMA MOUTH 1 0.0003
271 THROMBOSIS IN DEVICE 1 0.0003
272 INFUSION SITE HAEMORRHAGE 1 0.0003
273 LIGAMENT SPRAIN 3 0.0003
274 CEREBRAL HAEMATOMA 1 0.0003
275 NEPHROTIC SYNDROME 2 0.0003
276 JOINT EFFUSION 2 0.0003
277 PRIAPISM 1 0.0003
278 VIITH NERVE PARALYSIS 1 0.0003
279 CAROTID ARTERY STENOSIS 1 0.0003
280 THROMBOPHLEBITIS 1 0.0003
281 BONE EROSION 1 0.0003
282 HAEMORRHAGIC DIATHESIS 1 0.0003
283 PRODUCT SUPPLY ISSUE 2 0.0003
284 FACIAL BONES FRACTURE 1 0.0003
285 ACUTE MYOCARDIAL INFARCTION 8 0.0003
286 CARDIAC DYSFUNCTION 1 0.0003
287 INTESTINAL PERFORATION 3 0.0003
288 JOINT SWELLING 32 0.0003
289 FACE INJURY 1 0.0003
290 INTERNAL HAEMORRHAGE 3 0.0003
291 HAEMODYNAMIC INSTABILITY 2 0.0003
292 NEOPLASM 3 0.0003
293 HAEMOLYSIS 2 0.0003
294 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
295 THERAPEUTIC PRODUCT EFFECT VARIABLE 1 0.0003
296 CARDIOPULMONARY FAILURE 1 0.0003
297 EPIGASTRIC DISCOMFORT 1 0.0003
298 PROCEDURAL HAEMORRHAGE 1 0.0003
299 VENOUS THROMBOSIS 1 0.0003
300 PNEUMOTHORAX 4 0.0003
301 BLOOD DISORDER 2 0.0002
302 ARTHRITIS BACTERIAL 1 0.0002
303 INJECTION SITE EXTRAVASATION 3 0.0002
304 ANAPHYLACTOID REACTION 1 0.0002
305 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
306 ABSCESS LIMB 1 0.0002
307 HEPATIC PAIN 1 0.0002
308 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
309 IMMOBILE 1 0.0002
310 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
311 LIGAMENT RUPTURE 1 0.0002
312 WHEELCHAIR USER 1 0.0002
313 ILEUS PARALYTIC 1 0.0002
314 THERAPY NON-RESPONDER 10 0.0002
315 VASCULAR DEVICE INFECTION 1 0.0002
316 DISEASE COMPLICATION 1 0.0002
317 UROSEPSIS 2 0.0002
318 RENAL FUNCTION TEST ABNORMAL 1 0.0002
319 CARDIO-RESPIRATORY ARREST 9 0.0002
320 AGRANULOCYTOSIS 4 0.0002
321 CARDIAC TAMPONADE 1 0.0002
322 PULSE ABSENT 1 0.0002
323 BRONCHOSPASM 3 0.0002
324 SUBDURAL HAEMATOMA 3 0.0002
325 HUMERUS FRACTURE 1 0.0002
326 SEPTIC SHOCK 9 0.0002
327 HYPOKINESIA 3 0.0002
328 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 6 0.0002
329 INFLAMMATORY BOWEL DISEASE 2 0.0002
330 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
331 BREATH SOUNDS ABNORMAL 1 0.0002
332 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
333 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
334 TOXIC ENCEPHALOPATHY 1 0.0002
335 CACHEXIA 1 0.0002
336 CEREBRAL ISCHAEMIA 1 0.0002
337 PERIPHERAL VASCULAR DISORDER 1 0.0002
338 SKIN NECROSIS 1 0.0002
339 CYANOSIS 3 0.0002
340 HEAD INJURY 6 0.0002
341 BEHAVIOUR DISORDER 1 0.0002
342 HYDROCEPHALUS 1 0.0002
343 ASPIRATION 2 0.0002
344 NONSPECIFIC REACTION 1 0.0002
345 GASTRIC ULCER HAEMORRHAGE 1 0.0002
346 INJECTION SITE INJURY 1 0.0002
347 NECROSIS 1 0.0002
348 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
349 PRODUCT LEAKAGE 1 0.0002
350 THROMBOSIS 14 0.0002
351 MULTI-ORGAN FAILURE 3 0.0002
352 ENTEROCOLITIS 1 0.0002
353 HYPERVENTILATION 1 0.0002
354 PROTHROMBIN TIME PROLONGED 1 0.0002
355 EPILEPSY 5 0.0002
356 CARDIOMEGALY 2 0.0002
357 OLIGURIA 1 0.0002
358 TOOTH EXTRACTION 2 0.0002
359 SCREAMING 1 0.0002
360 CONTUSION 15 0.0002
361 ERECTILE DYSFUNCTION 4 0.0002
362 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
363 ANGINA UNSTABLE 1 0.0002
364 STAPHYLOCOCCAL INFECTION 5 0.0002
365 JOINT RANGE OF MOTION DECREASED 2 0.0001
366 COLITIS ISCHAEMIC 1 0.0001
367 WRONG PRODUCT ADMINISTERED 1 0.0001
368 TACHYPNOEA 2 0.0001
369 PALLOR 4 0.0001
370 RESPIRATORY DISTRESS 4 0.0001
371 PERITONITIS 3 0.0001
372 DROOLING 1 0.0001
373 ENCEPHALITIS 1 0.0001
374 MASS 2 0.0001
375 WOUND 4 0.0001
376 HEPATOCELLULAR INJURY 2 0.0001
377 DEEP VEIN THROMBOSIS 9 0.0001
378 FAECES SOFT 1 0.0001
379 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
380 PULMONARY EMBOLISM 13 0.0001
381 RENAL FAILURE 18 0.0001
382 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
383 PRODUCT AVAILABILITY ISSUE 3 0.0001
384 DRUG ADMINISTRATION ERROR 4 0.0001
385 SWELLING 12 0.0001
386 MULTIPLE ALLERGIES 1 0.0001
387 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
388 PRODUCT USE COMPLAINT 2 0.0001
389 FURUNCLE 1 0.0001
390 ARTHROPATHY 7 0.0001
391 RENAL CYST 1 0.0001
392 LOCALISED INFECTION 3 0.0001
393 CEREBRAL INFARCTION 3 0.0001
394 DECUBITUS ULCER 1 0.0001
395 ASPHYXIA 1 0.0001
396 ABASIA 3 0.0001
397 EPISTAXIS 9 0.0001
398 HEMIPLEGIA 1 0.0001
399 PYELONEPHRITIS 1 0.0001
400 DELIRIUM 4 0.0001
401 HYPERKALAEMIA 4 0.0001
402 GROIN PAIN 1 0.0001
403 IMMUNOSUPPRESSION 1 0.0001
404 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
405 WRONG DRUG ADMINISTERED 1 0.0001
406 HAEMOLYTIC ANAEMIA 1 0.0001
407 OEDEMA 6 0.0001
408 END STAGE RENAL DISEASE 2 0.0001
409 ANAPHYLACTIC REACTION 6 0.0001
410 IRON DEFICIENCY ANAEMIA 1 0.0001
411 PERSONALITY CHANGE 1 0.0001
412 SEPSIS 12 0.0001
413 HAEMOPTYSIS 3 0.0001
414 HEPATIC FUNCTION ABNORMAL 4 0.0001
415 APPENDICITIS 1 0.0001
416 FLANK PAIN 1 0.0001
417 LACERATION 1 0.0001
418 BLOOD URINE PRESENT 2 0.0001
419 ATELECTASIS 1 0.0001
420 DYSSTASIA 3 0.0001
421 CELLULITIS 5 0.0001
422 SUBARACHNOID HAEMORRHAGE 1 0.0001
423 BODY TEMPERATURE INCREASED 2 0.0001
424 FEMUR FRACTURE 3 0.0001
425 ROAD TRAFFIC ACCIDENT 4 0.0001
426 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
427 JOINT DISLOCATION 1 0.0001
428 SUDDEN DEATH 1 0.0001
429 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
430 DECREASED ACTIVITY 1 0.0001
431 SKIN LACERATION 1 0.0001
432 PRODUCT DISPENSING ERROR 2 0.0001
433 MELAENA 2 0.0001
434 TOOTH FRACTURE 1 0.0001
435 EXPIRED PRODUCT ADMINISTERED 3 0.0001
436 FOOT DEFORMITY 1 0.0001
437 FALL 30 0.0001
438 NERVE INJURY 1 0.0001
439 OXYGEN SATURATION DECREASED 5 0.0001
440 STATUS EPILEPTICUS 1 0.0001
441 IMPAIRED DRIVING ABILITY 1 0.0001
442 CHOLECYSTECTOMY 1 0.0001
443 MYOCARDIAL INFARCTION 15 0.0001
444 VASCULITIS 1 0.0001
445 PERIPHERAL SWELLING 13 0.0001
446 BACTERAEMIA 1 0.0001
447 CHOLECYSTITIS 1 0.0001
448 MACULAR DEGENERATION 1 0.0001
449 WRIST FRACTURE 1 0.0001
450 DRUG EFFECT INCOMPLETE 3 0.0001
451 THERAPEUTIC RESPONSE DECREASED 5 0.0001
452 NO THERAPEUTIC RESPONSE 1 0.0001
453 CYST 1 0.0001
454 DERMATITIS ALLERGIC 1 0.0001
455 MUSCLE ATROPHY 1 0.0001
456 HAEMATEMESIS 2 0.0001
457 INFUSION SITE PAIN 1 0.0001
458 RESPIRATORY TRACT INFECTION 2 0.0001
459 PLATELET COUNT INCREASED 1 0.0001
460 BEDRIDDEN 1 0.0001
461 ORAL CANDIDIASIS 1 0.0001
462 EYE HAEMORRHAGE 1 0.0001
463 QUALITY OF LIFE DECREASED 1 0.0001
464 ACUTE HEPATIC FAILURE 1 0.0001
465 RESPIRATORY ARREST 2 0.0001
466 ATRIAL FIBRILLATION 7 0.0001
467 FEELING COLD 2 0.0001
468 OSTEOARTHRITIS 3 0.0001
469 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
470 DRUG INEFFECTIVE 93 0.0001
471 DIALYSIS 1 0.0001
472 RECTAL HAEMORRHAGE 3 0.0001
473 ARTHRALGIA 29 0.0001
474 CARDIOGENIC SHOCK 1 0.0001
475 INJECTION SITE HAEMATOMA 1 0.0001
476 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
477 CARDIOMYOPATHY 1 0.0001
478 HEPATIC FAILURE 2 0.0001
479 APHASIA 2 0.0001
480 OSTEOPENIA 1 0.0001
481 DISCOMFORT 4 0.0001
482 SKIN DISCOLOURATION 3 0.0001
483 CEREBROVASCULAR ACCIDENT 11 0.0001
484 MUSCULOSKELETAL CHEST PAIN 1 0.0001
485 ANKLE FRACTURE 1 0.0001
486 ARTHRITIS 5 0.0001
487 OCULAR HYPERAEMIA 3 0.0001
488 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
489 OBESITY 1 0.0001
490 INJECTION SITE HAEMORRHAGE 5 0.0001
491 MOVEMENT DISORDER 2 0.0001
492 INTERSTITIAL LUNG DISEASE 3 0.0001
493 OSTEONECROSIS 2 0.0001
494 DRUG LEVEL INCREASED 1 0.0001
495 INFUSION RELATED REACTION 4 0.0001
496 COAGULOPATHY 1 0.0001
497 GAIT INABILITY 2 0.0001
498 BLOOD UREA INCREASED 1 0.0001
499 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
500 FACE OEDEMA 1 0.0001
501 HEMIPARESIS 1 0.0001
502 CIRCULATORY COLLAPSE 1 0.0001
503 MUSCULOSKELETAL DISCOMFORT 1 0.0001
504 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
505 EOSINOPHILIA 1 0.0001
506 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
507 GOUT 1 0.0001
508 DRUG EFFECT DECREASED 3 0.0001
509 INFECTION 8 0.0001
510 LEUKOCYTOSIS 1 0.0001
511 OSTEOMYELITIS 1 0.0001
512 BONE DISORDER 1 0.0001
513 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
514 RESTLESSNESS 2 0.0001
515 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
516 EYE SWELLING 2 0.0001
517 URTICARIA 9 0.0001
518 HEPATIC STEATOSIS 1 0.0001
519 HYPOCALCAEMIA 1 0.0001
520 PNEUMONIA 17 0.0001
521 POST PROCEDURAL COMPLICATION 1 0.0001
522 HERNIA 1 0.0001
523 ABNORMAL BEHAVIOUR 2 0.0001
524 DISORIENTATION 2 0.0001
525 HAEMATOCRIT DECREASED 1 0.0001
526 UPPER LIMB FRACTURE 1 0.0001
527 CYTOKINE RELEASE SYNDROME 1 0.0000
528 CARDIAC FAILURE 4 0.0000
529 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
530 PRODUCT ADMINISTRATION ERROR 1 0.0000
531 OEDEMA PERIPHERAL 6 0.0000
532 BONE MARROW FAILURE 1 0.0000
533 PRODUCT PREPARATION ERROR 1 0.0000
534 HYPERSENSITIVITY 9 0.0000
535 CARDIAC ARREST 4 0.0000
536 TOOTH LOSS 1 0.0000
537 POLLAKIURIA 2 0.0000
538 EATING DISORDER 1 0.0000
539 URINARY TRACT INFECTION 8 0.0000
540 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
541 PRODUCT PRESCRIBING ISSUE 1 0.0000
542 PAIN 28 0.0000
543 TOOTH DISORDER 1 0.0000
544 THROMBOCYTOPENIA 5 0.0000
545 ORAL PAIN 1 0.0000
546 RASH PAPULAR 1 0.0000
547 OFF LABEL USE 39 0.0000
548 SHOCK 1 0.0000
549 SEIZURE 5 0.0000
550 PERICARDIAL EFFUSION 1 0.0000
551 INJURY 3 0.0000
552 COMA 2 0.0000
553 RESPIRATORY FAILURE 3 0.0000
554 PRESYNCOPE 1 0.0000
555 AGITATION 3 0.0000
556 ENCEPHALOPATHY 1 0.0000
557 HYPOAESTHESIA 6 0.0000
558 PNEUMONIA ASPIRATION 1 0.0000
559 HYPOTENSION 8 0.0000
560 UNEVALUABLE EVENT 3 0.0000
561 CARDIOVASCULAR DISORDER 1 0.0000
562 HYPOPHAGIA 1 0.0000
563 LOSS OF CONSCIOUSNESS 5 0.0000
564 DRUG RESISTANCE 1 0.0000
565 ILLNESS 4 0.0000
566 ANAPHYLACTIC SHOCK 1 0.0000
567 INFLAMMATION 2 0.0000
568 UNRESPONSIVE TO STIMULI 1 0.0000
569 SEDATION 1 0.0000
570 ANHEDONIA 1 0.0000
571 EAR INFECTION 1 0.0000
572 PLATELET COUNT DECREASED 4 0.0000
573 DEATH 32 0.0000
574 BLOOD BILIRUBIN INCREASED 1 0.0000
575 THROAT TIGHTNESS 1 0.0000
576 PNEUMONITIS 1 0.0000
577 ANAEMIA 7 0.0000
578 TREATMENT NONCOMPLIANCE 2 0.0000
579 SKIN LESION 1 0.0000
580 PANCYTOPENIA 2 0.0000
581 DEMENTIA 1 0.0000
582 WEIGHT INCREASED 8 0.0000
583 RENAL IMPAIRMENT 3 0.0000
584 ANGINA PECTORIS 1 0.0000
585 PYREXIA 12 0.0000
586 CHILLS 4 0.0000
587 TACHYCARDIA 3 0.0000
588 CATARACT 2 0.0000
589 RESPIRATORY DISORDER 1 0.0000
590 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
591 EMOTIONAL DISTRESS 4 0.0000
592 CORONARY ARTERY DISEASE 1 0.0000
593 BLOOD PRESSURE INCREASED 5 0.0000
594 EMOTIONAL DISORDER 1 0.0000
595 LIMB DISCOMFORT 1 0.0000
596 WEIGHT DECREASED 9 0.0000
597 COUGH 9 0.0000
598 SWOLLEN TONGUE 1 0.0000
599 BONE DENSITY DECREASED 1 0.0000
600 VOMITING 15 0.0000
601 DYSPHAGIA 3 0.0000
602 GAIT DISTURBANCE 6 0.0000
603 METABOLIC ACIDOSIS 1 0.0000
604 HIP FRACTURE 1 0.0000
605 DRUG INTOLERANCE 3 0.0000
606 HYPERHIDROSIS 4 0.0000
607 LACTIC ACIDOSIS 1 0.0000
608 INCORRECT DOSE ADMINISTERED 7 0.0000
609 CHOLELITHIASIS 1 0.0000
610 IMPAIRED HEALING 1 0.0000
611 VIRAL INFECTION 1 0.0000
612 DYSPNOEA 17 0.0000
613 SYNCOPE 3 0.0000
614 URINARY RETENTION 1 0.0000
615 CONDITION AGGRAVATED 9 0.0000
616 CHEST DISCOMFORT 3 0.0000
617 HAEMOGLOBIN DECREASED 3 0.0000
618 ERYTHEMA 6 0.0000
619 RASH MACULAR 1 0.0000
620 LYMPHADENOPATHY 1 0.0000
621 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
622 MOBILITY DECREASED 2 0.0000
623 CRYING 1 0.0000
624 C-REACTIVE PROTEIN INCREASED 1 0.0000
625 HYPERGLYCAEMIA 1 0.0000
626 DYSURIA 1 0.0000
627 PRODUCT USE ISSUE 5 0.0000
628 INTESTINAL OBSTRUCTION 1 0.0000
629 EXTRA DOSE ADMINISTERED 1 0.0000
630 PRODUCT USE IN UNAPPROVED INDICATION 6 0.0000
631 TREMOR 4 0.0000
632 RHABDOMYOLYSIS 1 0.0000
633 PAIN IN EXTREMITY 7 0.0000
634 BALANCE DISORDER 2 0.0000
635 VAGINAL HAEMORRHAGE 1 0.0000
636 DEVICE DISLOCATION 1 0.0000
637 MENTAL DISORDER 1 0.0000
638 PULMONARY OEDEMA 1 0.0000
639 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
640 THROAT IRRITATION 1 0.0000
641 NEUTROPENIA 3 0.0000
642 CHEST PAIN 4 0.0000
643 ABDOMINAL PAIN 5 0.0000
644 RENAL DISORDER 1 0.0000
645 NEUROPATHY PERIPHERAL 2 0.0000
646 DISEASE RECURRENCE 1 0.0000
647 RASH ERYTHEMATOUS 1 0.0000
648 HYPOGLYCAEMIA 1 0.0000
649 LEUKOPENIA 1 0.0000
650 AGGRESSION 1 0.0000
651 FLUSHING 2 0.0000
652 FLUID RETENTION 1 0.0000
653 ABDOMINAL DISTENSION 2 0.0000
654 NERVOUSNESS 1 0.0000
655 MUSCULOSKELETAL PAIN 1 0.0000
656 DERMATITIS ATOPIC 1 0.0000
657 BRADYCARDIA 1 0.0000
658 HAEMATOCHEZIA 1 0.0000
659 INFLUENZA 2 0.0000
660 MYALGIA 3 0.0000
661 MUSCULAR WEAKNESS 2 0.0000
662 HEADACHE 11 0.0000
663 CONVULSION 1 0.0000
664 LETHARGY 1 0.0000
665 BACK PAIN 4 0.0000
666 COVID-19 3 0.0000
667 PALPITATIONS 2 0.0000
668 IRRITABILITY 1 0.0000
669 NO ADVERSE EVENT 3 0.0000
670 PLEURAL EFFUSION 1 0.0000
671 FEELING HOT 1 0.0000
672 RASH 7 0.0000
673 ASTHENIA 6 0.0000
674 SWELLING FACE 1 0.0000
675 BLOOD CREATININE INCREASED 1 0.0000
676 FEBRILE NEUTROPENIA 1 0.0000
677 BLOOD PRESSURE DECREASED 1 0.0000
678 SOMNOLENCE 3 0.0000
679 INJECTION SITE REACTION 1 0.0000
680 SLEEP DISORDER 1 0.0000
681 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
682 UNDERDOSE 1 0.0000
683 PRODUCT DOSE OMISSION ISSUE 4 0.0000
684 INJECTION SITE SWELLING 1 0.0000
685 PRURITUS 5 0.0000
686 DRUG INTERACTION 2 0.0000
687 INJECTION SITE BRUISING 1 0.0000
688 CARDIAC FAILURE CONGESTIVE 1 0.0000
689 PROSTATE CANCER 1 0.0000
690 SKIN EXFOLIATION 1 0.0000
691 INTENTIONAL PRODUCT MISUSE 1 0.0000
692 MUSCULOSKELETAL STIFFNESS 1 0.0000
693 MALAISE 5 0.0000
694 DEVICE ISSUE 1 0.0000
695 ADVERSE DRUG REACTION 1 0.0000
696 MUSCLE SPASMS 2 0.0000
697 OROPHARYNGEAL PAIN 1 0.0000
698 CARDIAC DISORDER 1 0.0000
699 OVERDOSE 2 0.0000
700 CONSTIPATION 2 0.0000
701 DEPRESSION 2 0.0000
702 FEELING ABNORMAL 2 0.0000
703 VISUAL IMPAIRMENT 1 0.0000
704 NAUSEA 6 0.0000
705 DEHYDRATION 1 0.0000
706 DRY SKIN 1 0.0000
707 PRODUCT QUALITY ISSUE 1 0.0000
708 VISION BLURRED 1 0.0000
709 ANXIETY 2 0.0000
710 HOSPITALISATION 1 0.0000
711 PARAESTHESIA 1 0.0000
712 DRUG DEPENDENCE 1 0.0000
713 CONFUSIONAL STATE 1 0.0000
714 DRUG DOSE OMISSION 1 0.0000
715 DIZZINESS 3 0.0000
716 ABDOMINAL DISCOMFORT 1 0.0000
717 NASOPHARYNGITIS 1 0.0000
718 FATIGUE 4 0.0000
719 ALOPECIA 1 0.0000
720 ABDOMINAL PAIN UPPER 1 0.0000
721 HYPERTENSION 1 0.0000
722 DECREASED APPETITE 1 0.0000
723 DIARRHOEA 2 0.0000